Exousia Pro（MAJI）株式概要Marijuana Inc.は米国で大麻製品を販売している。 詳細MAJI ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析収益が 100 万ドル未満 ( $-13K )US市場と比較して、過去 3 か月間の株価の変動が非常に大きいマイナスの株主資本 意味のある時価総額がありません ( $617K )+2 さらなるリスクすべてのリスクチェックを見るMAJI Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.011該当なし内在価値ディスカウントEst. Revenue$PastFuture-807k4082016201920222025202620282031Revenue US$1.0Earnings US$0.2AdvancedSet Fair ValueView all narrativesExousia Pro, Inc. 競合他社Silexion TherapeuticsSymbol: NasdaqCM:SLXNMarket cap: US$1.6mOnconetixSymbol: NasdaqCM:ONCOMarket cap: US$84.5kSunshine BiopharmaSymbol: NasdaqCM:SBFMMarket cap: US$2.5mPropanc BiopharmaSymbol: NasdaqCM:PPCBMarket cap: US$1.4m価格と性能株価の高値、安値、推移の概要Exousia Pro過去の株価現在の株価US$0.01152週高値US$0.2152週安値US$0.0092ベータ-4.871ヶ月の変化-38.55%3ヶ月変化-67.30%1年変化-94.50%3年間の変化-89.00%5年間の変化-93.82%IPOからの変化-99.75%最新ニュースお知らせ • May 12NexTel Medical Corp Enters Final Stage for Commercial LaunchNexTel Medical Corp. announced the commencement of the final stability phase for its inaugural line of commercial exosome products. Last week, NexTel successfully initiated the stability testing phase, a critical precursor to market entry. Under the supervision of Lab Director and Dr. Hausman, a production batch underwent rigorous filtration and diagnostic screening. Utilizing advanced PCR technology, samples were tested for common contaminants, using a threshold of (“0”), including: Shiga-like toxin-producing E. coli, Salmonella, Pseudomonas aeruginosa, Staphylococcus aureus. The samples tested negative for all four organisms. Currently, stability vials are being monitored at both room temperature and refrigeration. Success at the 30-day mark will allow NexTel to proceed with an immediate commercial launch, establishing a definitive shelf life for additive-free, pure exosome products.お知らせ • Mar 17Exousia Pro, Inc. Announces Favorable Litigation Settlement Highlighting Significant Debt Elimination And Share Cancellation To Enhance Shareholder ValueExousia Pro, Inc. had announced the successful settlement of its outstanding litigation involving a former Director. This landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value to current shareholders by improving the capital structure and strengthening the balance sheet. Under the terms of the settlement, which is expected to close within 30 days, Exousia Pro will make a one-time, strategic payment of $147,500 to the involved parties. In exchange, the Company will secure highly favorable financial restructuring outcomes. For the purposes of the Company’s upcoming financial reporting and audits, these events will be recorded under Generally Accepted Accounting Principles (GAAP) and will provide the following distinct benefits to the Company and its shareholders: Significant Debt Reduction: The settlement triggers the complete cancellation of a $200,000 promissory note issued at closing, as well as the cancellation of the remaining balance on the note tied to the control block of Preferred Stock. Removing these liabilities immediately strengthens Exousia's balance sheet and frees up future cash flow. Reversal of Share Dilution: The agreement secures the cancellation and return to treasury of 6,297,511 shares of Common Stock. Retiring this sizable block of shares reverses prior dilution, directly increasing the equity value, earnings-per-share potential, and ownership percentage of all current shareholders. Enhanced Audit Readiness and Transparency: By formally clearing these contested liabilities and equity issuances from the general ledger under GAAP, the Company is positioned for a clean, streamlined audit. This provides greater financial transparency and reinforces confidence within the investment community. By resolving this legacy dispute efficiently, Exousia Pro’s management team can now focus entirely on advancing its core clinical pipeline and expanding its telehealth initiatives without the distraction or financial overhang of litigation.お知らせ • Nov 18LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million.LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million on November 11, 2025. For consideration, 62.22 million shares of LAMY common stock will be given to the shareholders of Exousia Ai. The trannsaction was subject to approval from LAMY board and the same was approved. LAMY (OTCPK:LMMY) completed the acquisition of Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) on November 17, 2025.お知らせ • Jan 07Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG).Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025. As part of consideration, cash and stock of 47 million restricted shares of its Common stock is paid to Ludwig Enterprises. Marijuana Inc. further agreed to assume liabilities under $0.075 million and issued Ludwig a Note for $0.1 million. Marijuana Inc. (OTCPK:MAJI) completed the acquisition of Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025.お知らせ • May 24GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc.GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc. on May 23, 2023. As a result of the merger, existing equity holders of Marijuana Inc. have exchanged their shares for equity in the consolidated public company. The combined entity is poised to capitalize on the synergies between the two organizations, fostering operational efficiencies and unlocking new avenues for value creation. GRN Holding Corporation (OTCPK:GRNF) completed the acquisition of Marijuana, Inc. on May 23, 2023.お知らせ • Aug 06+ 1 more updateGRN Holdings Corporation, Inc. Appoints Donald Steinberg as DirectorGRN Holdings Corporation Inc. announced the appointment of Donald Steinberg as Director, the Company’s former CEO, has resigned from the Company’s board of directors, leaving Donald Steinberg as the Company’s sole director. Don has decades of involvement in the Marijuana Industry, going back to the 70’s when he was noted as the largest importer of Marijuana into the U.S. While in Marijuana “college” he studied stock options and wrote option volatility programs that he implemented on all of the option exchanges in the U.S. After that and seeing the large use of phone cards in Europe, he founded GlobalCom2000 which became a premier phone card company in the U.S. namely with the 7-11 card, the 1st card in the U.S. with a corporate logo and distribution in hundreds of 7-11 stores. He then went on to create One World Communications, which became the largest telecom affiliate marketing company in the world with 187 offices and training centers in over 30 countries and 200,000 affiliates. After One World Communications, he created Club Vivanet to provide financial services. In 2009, he formed Medical Marijuana Inc., which was the 1st company to be on a U.S. stock market. After building the market cap of Medical Marijuana Inc. to a market cap of nearly $100 million, he retired to Florida. In 2015, he formed Marijuana Company of America and resigned in 2019. In that year, he formed Marijuana Strategic Ventures to assist companies in the “going public process”. He recently changed the name of that company to Mushrooms Inc. to participate in the Mushrooms industry.最新情報をもっと見るRecent updatesお知らせ • May 12NexTel Medical Corp Enters Final Stage for Commercial LaunchNexTel Medical Corp. announced the commencement of the final stability phase for its inaugural line of commercial exosome products. Last week, NexTel successfully initiated the stability testing phase, a critical precursor to market entry. Under the supervision of Lab Director and Dr. Hausman, a production batch underwent rigorous filtration and diagnostic screening. Utilizing advanced PCR technology, samples were tested for common contaminants, using a threshold of (“0”), including: Shiga-like toxin-producing E. coli, Salmonella, Pseudomonas aeruginosa, Staphylococcus aureus. The samples tested negative for all four organisms. Currently, stability vials are being monitored at both room temperature and refrigeration. Success at the 30-day mark will allow NexTel to proceed with an immediate commercial launch, establishing a definitive shelf life for additive-free, pure exosome products.お知らせ • Mar 17Exousia Pro, Inc. Announces Favorable Litigation Settlement Highlighting Significant Debt Elimination And Share Cancellation To Enhance Shareholder ValueExousia Pro, Inc. had announced the successful settlement of its outstanding litigation involving a former Director. This landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value to current shareholders by improving the capital structure and strengthening the balance sheet. Under the terms of the settlement, which is expected to close within 30 days, Exousia Pro will make a one-time, strategic payment of $147,500 to the involved parties. In exchange, the Company will secure highly favorable financial restructuring outcomes. For the purposes of the Company’s upcoming financial reporting and audits, these events will be recorded under Generally Accepted Accounting Principles (GAAP) and will provide the following distinct benefits to the Company and its shareholders: Significant Debt Reduction: The settlement triggers the complete cancellation of a $200,000 promissory note issued at closing, as well as the cancellation of the remaining balance on the note tied to the control block of Preferred Stock. Removing these liabilities immediately strengthens Exousia's balance sheet and frees up future cash flow. Reversal of Share Dilution: The agreement secures the cancellation and return to treasury of 6,297,511 shares of Common Stock. Retiring this sizable block of shares reverses prior dilution, directly increasing the equity value, earnings-per-share potential, and ownership percentage of all current shareholders. Enhanced Audit Readiness and Transparency: By formally clearing these contested liabilities and equity issuances from the general ledger under GAAP, the Company is positioned for a clean, streamlined audit. This provides greater financial transparency and reinforces confidence within the investment community. By resolving this legacy dispute efficiently, Exousia Pro’s management team can now focus entirely on advancing its core clinical pipeline and expanding its telehealth initiatives without the distraction or financial overhang of litigation.お知らせ • Nov 18LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million.LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million on November 11, 2025. For consideration, 62.22 million shares of LAMY common stock will be given to the shareholders of Exousia Ai. The trannsaction was subject to approval from LAMY board and the same was approved. LAMY (OTCPK:LMMY) completed the acquisition of Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) on November 17, 2025.お知らせ • Jan 07Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG).Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025. As part of consideration, cash and stock of 47 million restricted shares of its Common stock is paid to Ludwig Enterprises. Marijuana Inc. further agreed to assume liabilities under $0.075 million and issued Ludwig a Note for $0.1 million. Marijuana Inc. (OTCPK:MAJI) completed the acquisition of Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025.お知らせ • May 24GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc.GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc. on May 23, 2023. As a result of the merger, existing equity holders of Marijuana Inc. have exchanged their shares for equity in the consolidated public company. The combined entity is poised to capitalize on the synergies between the two organizations, fostering operational efficiencies and unlocking new avenues for value creation. GRN Holding Corporation (OTCPK:GRNF) completed the acquisition of Marijuana, Inc. on May 23, 2023.お知らせ • Aug 06+ 1 more updateGRN Holdings Corporation, Inc. Appoints Donald Steinberg as DirectorGRN Holdings Corporation Inc. announced the appointment of Donald Steinberg as Director, the Company’s former CEO, has resigned from the Company’s board of directors, leaving Donald Steinberg as the Company’s sole director. Don has decades of involvement in the Marijuana Industry, going back to the 70’s when he was noted as the largest importer of Marijuana into the U.S. While in Marijuana “college” he studied stock options and wrote option volatility programs that he implemented on all of the option exchanges in the U.S. After that and seeing the large use of phone cards in Europe, he founded GlobalCom2000 which became a premier phone card company in the U.S. namely with the 7-11 card, the 1st card in the U.S. with a corporate logo and distribution in hundreds of 7-11 stores. He then went on to create One World Communications, which became the largest telecom affiliate marketing company in the world with 187 offices and training centers in over 30 countries and 200,000 affiliates. After One World Communications, he created Club Vivanet to provide financial services. In 2009, he formed Medical Marijuana Inc., which was the 1st company to be on a U.S. stock market. After building the market cap of Medical Marijuana Inc. to a market cap of nearly $100 million, he retired to Florida. In 2015, he formed Marijuana Company of America and resigned in 2019. In that year, he formed Marijuana Strategic Ventures to assist companies in the “going public process”. He recently changed the name of that company to Mushrooms Inc. to participate in the Mushrooms industry.株主還元MAJIUS BiotechsUS 市場7D2.9%1.2%1.0%1Y-94.5%34.9%28.7%株主還元を見る業界別リターン: MAJI過去 1 年間で34.9 % の収益を上げたUS Biotechs業界を下回りました。リターン対市場: MAJIは、過去 1 年間で28.7 % のリターンを上げたUS市場を下回りました。価格変動Is MAJI's price volatile compared to industry and market?MAJI volatilityMAJI Average Weekly Movement29.8%Biotechs Industry Average Movement11.0%Market Average Movement7.2%10% most volatile stocks in US Market16.4%10% least volatile stocks in US Market3.1%安定した株価: MAJIの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: MAJIの 週次ボラティリティ は過去 1 年間で36%から30%に減少しましたが、依然としてUS株の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト20103Don Steinbergwww.exousiapro.comMarijuana Inc.は米国で大麻製品を販売している。旧社名はGRN Holding Corporationで、2024年10月に社名をMarijuana Inc.に変更した。は2010年に設立され、フロリダ州エステロに拠点を置く。もっと見るExousia Pro, Inc. 基礎のまとめExousia Pro の収益と売上を時価総額と比較するとどうか。MAJI 基礎統計学時価総額US$616.53k収益（TTM）-US$661.35k売上高(TTM)n/a-48.1xP/Sレシオ-0.9xPER（株価収益率MAJI は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計MAJI 損益計算書（TTM）収益-US$12.83k売上原価US$0売上総利益-US$12.83kその他の費用US$648.52k収益-US$661.35k直近の収益報告Mar 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.012グロス・マージン100.00%純利益率5,154.75%有利子負債／自己資本比率-108.3%MAJI の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 07:13終値2026/05/22 00:00収益2025/03/31年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Exousia Pro, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 12NexTel Medical Corp Enters Final Stage for Commercial LaunchNexTel Medical Corp. announced the commencement of the final stability phase for its inaugural line of commercial exosome products. Last week, NexTel successfully initiated the stability testing phase, a critical precursor to market entry. Under the supervision of Lab Director and Dr. Hausman, a production batch underwent rigorous filtration and diagnostic screening. Utilizing advanced PCR technology, samples were tested for common contaminants, using a threshold of (“0”), including: Shiga-like toxin-producing E. coli, Salmonella, Pseudomonas aeruginosa, Staphylococcus aureus. The samples tested negative for all four organisms. Currently, stability vials are being monitored at both room temperature and refrigeration. Success at the 30-day mark will allow NexTel to proceed with an immediate commercial launch, establishing a definitive shelf life for additive-free, pure exosome products.
お知らせ • Mar 17Exousia Pro, Inc. Announces Favorable Litigation Settlement Highlighting Significant Debt Elimination And Share Cancellation To Enhance Shareholder ValueExousia Pro, Inc. had announced the successful settlement of its outstanding litigation involving a former Director. This landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value to current shareholders by improving the capital structure and strengthening the balance sheet. Under the terms of the settlement, which is expected to close within 30 days, Exousia Pro will make a one-time, strategic payment of $147,500 to the involved parties. In exchange, the Company will secure highly favorable financial restructuring outcomes. For the purposes of the Company’s upcoming financial reporting and audits, these events will be recorded under Generally Accepted Accounting Principles (GAAP) and will provide the following distinct benefits to the Company and its shareholders: Significant Debt Reduction: The settlement triggers the complete cancellation of a $200,000 promissory note issued at closing, as well as the cancellation of the remaining balance on the note tied to the control block of Preferred Stock. Removing these liabilities immediately strengthens Exousia's balance sheet and frees up future cash flow. Reversal of Share Dilution: The agreement secures the cancellation and return to treasury of 6,297,511 shares of Common Stock. Retiring this sizable block of shares reverses prior dilution, directly increasing the equity value, earnings-per-share potential, and ownership percentage of all current shareholders. Enhanced Audit Readiness and Transparency: By formally clearing these contested liabilities and equity issuances from the general ledger under GAAP, the Company is positioned for a clean, streamlined audit. This provides greater financial transparency and reinforces confidence within the investment community. By resolving this legacy dispute efficiently, Exousia Pro’s management team can now focus entirely on advancing its core clinical pipeline and expanding its telehealth initiatives without the distraction or financial overhang of litigation.
お知らせ • Nov 18LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million.LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million on November 11, 2025. For consideration, 62.22 million shares of LAMY common stock will be given to the shareholders of Exousia Ai. The trannsaction was subject to approval from LAMY board and the same was approved. LAMY (OTCPK:LMMY) completed the acquisition of Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) on November 17, 2025.
お知らせ • Jan 07Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG).Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025. As part of consideration, cash and stock of 47 million restricted shares of its Common stock is paid to Ludwig Enterprises. Marijuana Inc. further agreed to assume liabilities under $0.075 million and issued Ludwig a Note for $0.1 million. Marijuana Inc. (OTCPK:MAJI) completed the acquisition of Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025.
お知らせ • May 24GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc.GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc. on May 23, 2023. As a result of the merger, existing equity holders of Marijuana Inc. have exchanged their shares for equity in the consolidated public company. The combined entity is poised to capitalize on the synergies between the two organizations, fostering operational efficiencies and unlocking new avenues for value creation. GRN Holding Corporation (OTCPK:GRNF) completed the acquisition of Marijuana, Inc. on May 23, 2023.
お知らせ • Aug 06+ 1 more updateGRN Holdings Corporation, Inc. Appoints Donald Steinberg as DirectorGRN Holdings Corporation Inc. announced the appointment of Donald Steinberg as Director, the Company’s former CEO, has resigned from the Company’s board of directors, leaving Donald Steinberg as the Company’s sole director. Don has decades of involvement in the Marijuana Industry, going back to the 70’s when he was noted as the largest importer of Marijuana into the U.S. While in Marijuana “college” he studied stock options and wrote option volatility programs that he implemented on all of the option exchanges in the U.S. After that and seeing the large use of phone cards in Europe, he founded GlobalCom2000 which became a premier phone card company in the U.S. namely with the 7-11 card, the 1st card in the U.S. with a corporate logo and distribution in hundreds of 7-11 stores. He then went on to create One World Communications, which became the largest telecom affiliate marketing company in the world with 187 offices and training centers in over 30 countries and 200,000 affiliates. After One World Communications, he created Club Vivanet to provide financial services. In 2009, he formed Medical Marijuana Inc., which was the 1st company to be on a U.S. stock market. After building the market cap of Medical Marijuana Inc. to a market cap of nearly $100 million, he retired to Florida. In 2015, he formed Marijuana Company of America and resigned in 2019. In that year, he formed Marijuana Strategic Ventures to assist companies in the “going public process”. He recently changed the name of that company to Mushrooms Inc. to participate in the Mushrooms industry.
お知らせ • May 12NexTel Medical Corp Enters Final Stage for Commercial LaunchNexTel Medical Corp. announced the commencement of the final stability phase for its inaugural line of commercial exosome products. Last week, NexTel successfully initiated the stability testing phase, a critical precursor to market entry. Under the supervision of Lab Director and Dr. Hausman, a production batch underwent rigorous filtration and diagnostic screening. Utilizing advanced PCR technology, samples were tested for common contaminants, using a threshold of (“0”), including: Shiga-like toxin-producing E. coli, Salmonella, Pseudomonas aeruginosa, Staphylococcus aureus. The samples tested negative for all four organisms. Currently, stability vials are being monitored at both room temperature and refrigeration. Success at the 30-day mark will allow NexTel to proceed with an immediate commercial launch, establishing a definitive shelf life for additive-free, pure exosome products.
お知らせ • Mar 17Exousia Pro, Inc. Announces Favorable Litigation Settlement Highlighting Significant Debt Elimination And Share Cancellation To Enhance Shareholder ValueExousia Pro, Inc. had announced the successful settlement of its outstanding litigation involving a former Director. This landmark agreement represents a pivotal financial milestone for the Company, delivering immediate and substantial value to current shareholders by improving the capital structure and strengthening the balance sheet. Under the terms of the settlement, which is expected to close within 30 days, Exousia Pro will make a one-time, strategic payment of $147,500 to the involved parties. In exchange, the Company will secure highly favorable financial restructuring outcomes. For the purposes of the Company’s upcoming financial reporting and audits, these events will be recorded under Generally Accepted Accounting Principles (GAAP) and will provide the following distinct benefits to the Company and its shareholders: Significant Debt Reduction: The settlement triggers the complete cancellation of a $200,000 promissory note issued at closing, as well as the cancellation of the remaining balance on the note tied to the control block of Preferred Stock. Removing these liabilities immediately strengthens Exousia's balance sheet and frees up future cash flow. Reversal of Share Dilution: The agreement secures the cancellation and return to treasury of 6,297,511 shares of Common Stock. Retiring this sizable block of shares reverses prior dilution, directly increasing the equity value, earnings-per-share potential, and ownership percentage of all current shareholders. Enhanced Audit Readiness and Transparency: By formally clearing these contested liabilities and equity issuances from the general ledger under GAAP, the Company is positioned for a clean, streamlined audit. This provides greater financial transparency and reinforces confidence within the investment community. By resolving this legacy dispute efficiently, Exousia Pro’s management team can now focus entirely on advancing its core clinical pipeline and expanding its telehealth initiatives without the distraction or financial overhang of litigation.
お知らせ • Nov 18LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million.LAMY (OTCPK:LMMY) entered into an agreement to acquire Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) for $10.6 million on November 11, 2025. For consideration, 62.22 million shares of LAMY common stock will be given to the shareholders of Exousia Ai. The trannsaction was subject to approval from LAMY board and the same was approved. LAMY (OTCPK:LMMY) completed the acquisition of Exousia Ai, Inc. from Marijuana Inc. (OTCPK:MAJI) on November 17, 2025.
お知らせ • Jan 07Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG).Marijuana Inc. (OTCPK:MAJI) acquired Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025. As part of consideration, cash and stock of 47 million restricted shares of its Common stock is paid to Ludwig Enterprises. Marijuana Inc. further agreed to assume liabilities under $0.075 million and issued Ludwig a Note for $0.1 million. Marijuana Inc. (OTCPK:MAJI) completed the acquisition of Exousia Ai, Inc. from Ludwig Enterprises, Inc. (OTCPK:LUDG) on January 6, 2025.
お知らせ • May 24GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc.GRN Holding Corporation (OTCPK:GRNF) acquired Marijuana, Inc. on May 23, 2023. As a result of the merger, existing equity holders of Marijuana Inc. have exchanged their shares for equity in the consolidated public company. The combined entity is poised to capitalize on the synergies between the two organizations, fostering operational efficiencies and unlocking new avenues for value creation. GRN Holding Corporation (OTCPK:GRNF) completed the acquisition of Marijuana, Inc. on May 23, 2023.
お知らせ • Aug 06+ 1 more updateGRN Holdings Corporation, Inc. Appoints Donald Steinberg as DirectorGRN Holdings Corporation Inc. announced the appointment of Donald Steinberg as Director, the Company’s former CEO, has resigned from the Company’s board of directors, leaving Donald Steinberg as the Company’s sole director. Don has decades of involvement in the Marijuana Industry, going back to the 70’s when he was noted as the largest importer of Marijuana into the U.S. While in Marijuana “college” he studied stock options and wrote option volatility programs that he implemented on all of the option exchanges in the U.S. After that and seeing the large use of phone cards in Europe, he founded GlobalCom2000 which became a premier phone card company in the U.S. namely with the 7-11 card, the 1st card in the U.S. with a corporate logo and distribution in hundreds of 7-11 stores. He then went on to create One World Communications, which became the largest telecom affiliate marketing company in the world with 187 offices and training centers in over 30 countries and 200,000 affiliates. After One World Communications, he created Club Vivanet to provide financial services. In 2009, he formed Medical Marijuana Inc., which was the 1st company to be on a U.S. stock market. After building the market cap of Medical Marijuana Inc. to a market cap of nearly $100 million, he retired to Florida. In 2015, he formed Marijuana Company of America and resigned in 2019. In that year, he formed Marijuana Strategic Ventures to assist companies in the “going public process”. He recently changed the name of that company to Mushrooms Inc. to participate in the Mushrooms industry.
